WAZZI-200 Suspension contains Azithromycin 200 mg and is positioned as a convenient paediatric oral antibiotic for selected susceptible bacterial infections. The liquid dosage form facilitates administration in children while supporting appropriate antibiotic therapy under medical supervision. A strong PCD Pharma Paediatric Antibiotic offering.
Selected bacterial infections.
No.
Administer strictly according to age/weight-based medical advice and complete the prescribed course. Inform the doctor about liver or heart-rhythm problems.
Nausea, diarrhea, vomiting, abdominal discomfort and headache may occur.
WAZZI-200 Susp: Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, providing antibacterial activity against susceptible organisms.
